Our research uncovered an exosomal miR-92b-3p/ELK4 signaling pathway that regulated osteoblast differentiation, suggesting that exosomes may be a promising therapeutic strategy for disuse osteoporosis. The gene discussed is ELK4; the disease is osteoporosis.